is a unique opportunity to receive CME/CE credits while staying ahead of the latest advances in immuno and molecular oncology.
The Annual PRIMO Meeting is designed to summarize key developments in cancer care over the past 12 months and features anticipated advances that you and your patients will likely see in the upcoming year.
The 2021 agenda is being curated by our Co-Chairs and Steering Committee to ensure that it meets the educational needs of all our attendees, with an emphasis on the following areas:
Practical considerations of applying biomarkers and targeted therapy
Integration of immunotherapy, with a focus on novel management approaches
Patient selection, as well as timing and sequencing of therapy
Dealing with important trends, such as big data and defining value in cancer care
An elite faculty is in the process of being assembled for the 2021 Annual PRIMO Meeting by our Steering Committee, led by our Co-Chairs Dr. Rugo and Dr. Vose
The PRIMO Meeting offers a fantastic opportunity for industry to interact with leading multidisciplinary oncologists and stay up to date with the latest information regarding targeted and immunologic therapies.
